SCHEMBL762914

SCHEMBL762914

Cc1cnc(Br)c(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30735720 1.00
SCHEMBL29690486 0.80
SCHEMBL342702 0.80
SCHEMBL2489172 0.79
SCHEMBL1126105 0.79
SCHEMBL29426953 0.79
SCHEMBL31180717 0.79
SCHEMBL305800 0.75
SCHEMBL15901334 0.75
SCHEMBL4058192 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104311508-A Synthetic method of iron-catalyzed phenothiazine compound UNIV SOOCHOW 2015-01-28 CN claimed
US-20250388583-A1 COMPOUNDS AND METHOD FOR PKMYT1 INHIBITION ENGINE BIOSCIENCES PTE LTD (SG) 2025-12-25 US disclosed
US-12065429-B2 Small molecule modulators of IL-17 LEO PHARMA A/S (DK) 2024-08-20 US disclosed
US-20240208938-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2024-06-27 US disclosed
CN-118239947-A Compound, intermediate, preparation method, pharmaceutical composition and application 上海艾力斯医药科技股份有限公司 2024-06-25 CN disclosed
WO-2024115662-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2024-06-06 WO disclosed
WO-2023249563-A1 COMPOUNDS AND METHOD FOR PKMYT1 INHIBITION ENGINE BIOSCIENCES PTE. LTD. (SG) 2023-12-28 WO disclosed
EP-4130004-A1 SALT AND CRYSTALLINE FORMS OF FGFR4 INHIBITOR AND USES THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2023-02-08 EP disclosed
EP-4019516-A1 ASYMMETRIC PHASE TRANSFER CATALYSIS Merck Sharp & Dohme Corp. (US) 2022-06-29 EP disclosed
EP-3848377-A1 FGFR4 INHIBITOR AND USE THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2021-07-14 EP disclosed
US-20090181947-A1 BICYCLIC ENAMINO(THIO)CARBONYL COMPOUNDS BAYER CROPSCIENCE AG (DE) 2009-07-16 US disclosed
EP-2049535-A1 ALPHA-CARBOLINE DERIVATIVES AND METHODS FOR PREPARATION THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-04-22 EP disclosed
EP-2049488-A2 N'-CYANO-N-ALKYL HALIDE IMIDE AMIDE DERIVATIVES Bayer CropScience AG (DE) 2009-04-22 EP disclosed
WO-2008016184-A1 ALPHA-CARBOLINE DERIVATIVES AND METHODS FOR PREPARATION THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 WO disclosed
WO-2008016184-A1 ALPHA-CARBOLINE DERIVATIVES AND METHODS FOR PREPARATION THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-02-07 WO disclosed
WO-2008009360-A2 N'-CYANO-N-ALKYL HALIDE IMIDE AMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2008-01-24 WO disclosed
WO-2007115643-A1 SUBSTITUTED ENAMINOCARBONYL COMPOUNDS BAYER CROPSCIENCE AG (DE) 2007-10-18 WO disclosed
WO-2007115647-A1 BICYCLIC ENAMINO(THIO)CARBONYL COMPOUNDS BAYER CROPSCIENCE AG (DE) 2007-10-18 WO disclosed
EP-0137415-B1 ADDITION OF POLYHALONITRILES TO FUNCTIONALIZED OLEFINS THE DOW CHEMICAL COMPANY (US) 1988-06-01 EP disclosed
EP-0137415-A2 Addition of polyhalonitriles to functionalized olefins THE DOW CHEMICAL COMPANY (US) 1985-04-17 EP disclosed